Structures by: Glen R. C.

Total: 4

4(C14H10Cl2NO21),4(Na1),19(H2O)

4(C14H10Cl2NO21),4(Na1),19(H2O)

Llinàs, AntonioBurley, Jonathan C.Box, Karl J.Glen, Robert C.Goodman, Jonathan M.

Journal of medicinal chemistry (2007) 50, 5 979-983

a=9.55400(10)Å   b=39.4910(4)Å   c=9.84120(10)Å

α=90.00°   β=90.7290(10)°   γ=90.00°

Sulindac

C20H17F1O3S1

Llinàs, AntonioBox, Karl J.Burley, Jonathan C.Glen, Robert C.Goodman, Jonathan M.

Journal of Applied Crystallography (2007) 40, 2 379-381

a=12.68581(34)Å   b=8.18939(20)Å   c=17.7934(5)Å

α=90.0°   β=106.0111(29)°   γ=90.0°

Sparfloxamine trihydrate

C19H22F2N4O3,3(H2O)

Llinàs, AntonioBurley, Jonathan C.Prior, Timothy J.Glen, Robert C.Goodman, Jonathan M.

Crystal Growth & Design (2008) 8, 1 114

a=9.1250(13)Å   b=10.3010(15)Å   c=11.8890(17)Å

α=90.00°   β=109.207(2)°   γ=90.00°

C19H22F2N4O3,3(H2O)

C19H22F2N4O3,3(H2O)

Llinàs, AntonioBurley, Jonathan C.Prior, Timothy J.Glen, Robert C.Goodman, Jonathan M.

Crystal Growth & Design (2008) 8, 1 114

a=9.1533(3)Å   b=10.3248(4)Å   c=11.9341(4)Å

α=90.00°   β=109.221(2)°   γ=90.00°